Yorba Linda, Ca (PRWEB) April 20, 2017
As part of the Stago EdVantage Virtual University Virtual Event, this new webinar will explore challenging patient cases when screening for direct oral anticoagulant. When patients taking direct oral anticoagulants (DOACs) are admitted to the hospital, there may be a need for bridging parental anticoagulation especially for those at high risk of thrombosis recurrence.
By presenting information on DOAC interference in laboratory assays, institutional experience, and case studies, this webinar will address questions surrounding management of patients on DOAC therapy. Attendees of this webinar will learn from instances when presented with challenging cases, and be able to show how traditional and other laboratory measures can help guide safe, appropriate therapy.
Participants will also be able to gain a better understanding of how to identify the effects of DOACs, as well as describe common errors that are seen in practice when the effect of DOACs on common anticoagulation laboratory measures is not realized.
The speaker for this event will be Dr. Michael P Gulseth, PharmD, BCPS, FASHP. He is the program director for Anticoagulation Services at Sanford USD Medical Center & Clinical. He is also an associate professor in the Department of Internal Medicine at the University of South Dakota Sanford School of Medicine.
Gulseth is a recognized expert in the area of anticoagulation administration and safety, having developed the 2017 ISMP Medication Safety Self-Assessment for Antithrombotic Therapy. He has authored numerous peer-reviewed publications in this area. In addition, he regularly serves as an editor for publications and presents at conferences of the American Society of Health-System Pharmacists (ASHP). He was elected as a fellow of the ASHP in 2011 and serves on the editorial advisory board of American Journal of Health-System Pharmacy (AJHP).
LabRoots will host the webinar April 26, 2017, commencing at 6:00 a.m. PDT. To learn more about the Stago EdVantage Virtual University Virtual Event, the continuing education credits offered, or to register for free, click here.
ABOUT DIAGNOSTICA STAGO, INC.
Diagnostica Stago, Inc. is the exclusive provider of the Diagnostica Stago Hemostasis product lines in the United States and offers a complete system of coagulation instruments and optimized reagent kits for research as well as for routine analysis. Diagnostica Stago, Inc. is the U.S. subsidiary of Diagnostica Stago, S.A.S. France, a leader in the development and manufacture of Hemostasis products. For more information about any Stago product or service, please call 800-222-COAG or visit our website at http://www.stago-us.com.
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.